Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients-Reference-Cited by-同舟云学术

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

Published:2013-06 Issue:6 Volume:21 Page:1212-1223
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Liikanen Ilkka,Ahtiainen Laura,Hirvinen Mari LM,Bramante Simona,Cerullo Vincenzo,Nokisalmi Petri,Hemminki Otto,Diaconu Iulia,Pesonen Sari,Koski Anniina,Kangasniemi Lotta,Pesonen Saila K,Oksanen Minna,Laasonen Leena,Partanen Kaarina,Joensuu Timo,Zhao Fang,Kanerva Anna,Hemminki Akseli

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus;Ito;J Natl Cancer Inst,2006

2. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity;Jiang;J Virol,2011

3. Autophagy as a therapeutic target in cancer;Chen;Cancer Biol Ther,2011

4. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice;Michaud;Science,2011

5. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death;Martins;Autophagy,2012

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment;Biomedicine & Pharmacotherapy;2024-08

2. The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?;Vaccines;2024-06-28

3. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy;Frontiers in Cell and Developmental Biology;2024-05-15

4. Nucleic acids based integrated macromolecular complexes for SiRNA delivery: Recent advancements;Nucleosides, Nucleotides & Nucleic Acids;2024-05

5. Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial;Clinical Cancer Research;2024-03-27